Home Research progress on ocular complications caused by type 2 diabetes mellitus and the function of tears and blepharons
Article Open Access

Research progress on ocular complications caused by type 2 diabetes mellitus and the function of tears and blepharons

  • Xiaohong Wang , Jian Fang EMAIL logo and Lina Yang
Published/Copyright: January 27, 2024

Abstract

The purpose of this study was to explore the related research progress of ocular complications (OCs) caused by type 2 diabetes mellitus (T2DM), tear and tarsal function, and the application of deep learning (DL) in the diagnosis of diabetes and OCs caused by it, to provide reference for the prevention and control of OCs in T2DM patients. This study reviewed the pathogenesis and treatment of diabetes retinopathy, keratopathy, dry eye disease, glaucoma, and cataract, analyzed the relationship between OCs and tear function and tarsal function, and discussed the application value of DL in the diagnosis of diabetes and OCs. Diabetes retinopathy is related to hyperglycemia, angiogenic factors, oxidative stress, hypertension, hyperlipidemia, and other factors. The increase in water content in the corneal stroma leads to corneal relaxation, loss of transparency, and elasticity, and can lead to the occurrence of corneal lesions. Dry eye syndrome is related to abnormal stability of the tear film and imbalance in neural and immune regulation. Elevated intraocular pressure, inflammatory reactions, atrophy of the optic nerve head, and damage to optic nerve fibers are the causes of glaucoma. Cataract is a common eye disease in the elderly, which is a visual disorder caused by lens opacity. Oxidative stress is an important factor in the occurrence of cataracts. In clinical practice, blood sugar control, laser therapy, and drug therapy are used to control the above eye complications. The function of tear and tarsal plate will be affected by eye diseases. Retinopathy and dry eye disease caused by diabetes will cause dysfunction of tear and tarsal plate, which will affect the eye function of patients. Furthermore, DL can automatically diagnose and classify eye diseases, automatically analyze fundus images, and accurately diagnose diabetes retinopathy, macular degeneration, and other diseases by analyzing and processing eye images and data. The treatment of T2DM is difficult and prone to OCs, which seriously threatens the normal life of patients. The occurrence of OCs is closely related to abnormal tear and tarsal function. Based on DL, clinical diagnosis and treatment of diabetes and its OCs can be carried out, which has positive application value.

1 Introduction

Type 2 diabetes mellitus (T2DM) is a common metabolic disease, long-term hyperglycemia will have an impact on all organs and systems of the whole body, in which organs such as eyes, cardiovascular system, kidney, and nervous system are vulnerable to damage [1]. Ocular complications (OCs) induced by T2DM will affect ocular function and cause significant complications. OCs caused by T2DM mainly include retinopathy and non-retinopathy [2]. Diabetes retinopathy is a kind of eye disease caused by diabetes, which is one of the main causes of blindness in adults worldwide. The occurrence mechanism of diabetes retinopathy involves many factors, including hyperglycemia, hypertension, and dyslipidemia [3]. Diabetes retinopathy has a serious impact on the health of diabetes patients, and it is necessary to take preventive measures in time. In recent years, diabetes related other OCs such as corneal disease, dry eye disease, cataract, glaucoma, fundus disease, and optic neuropathy have gradually attracted the attention of doctors and diabetes patients, and it is necessary to study the pathogenesis and treatment. Therefore, this work reviewed the pathogenesis and treatment of T2DM-induced OCs, and compared and analyzed different types of diabetes and eye diseases, to offer a theoretical guidance for preventing or treating T2DM-induced OCs of patients.

Tears and blepharons are two important parts of the eyes and have active physiological functions. Tear is a transparent liquid secreted by the lacrimal gland and mainly composed of water, salts, proteins, and other components [4]. Tears lubricate the surface of the eyeball, forming a thin film over it that keeps it moist and prevents dryness and irritation. Tears also clean the eyeball and is antibacterial and antiviral to prevent eye infections while supplying oxygen and nutrients to keep the eyeball healthy [5]. Previous studies on the changes of tear secretion function in diabetes patients have been inconsistent. Andersen et al. [6] pointed out that there was no significant difference in the amount of basic tear secretion between diabetes patients and normal controls; Yeung and Dwarakanathan [7] reported that 47% of diabetes patients had decreased tear secretion. Patnaik et al. [8] showed that there was no obvious abnormality in tear film function in diabetic patients.

Blepharons are small glands in the eyelid and the skin, hair, and muscle tissue at the edge of the eyelid. Blepharons can secrete oil, lubricate tears, form a protective film to prevent excessive evaporation of tears, maintain the stability of tears, prevent the rapid evaporation of tears, and protect eyes, exerting a very important role in maintaining eye health [9]. Diabetes can lead to dry eyes, making the eyelids easy to feel dry, itchy, or painful. Patients with diabetes are more likely to suffer from blepharitis, which causes skin inflammation at the blepharitis, often accompanied by redness, itching, crusting, and other symptoms [10]. The function of tears and blepharons will be affected by eye diseases. Retinopathy and dry eye disease induced by diabetes will cause functional abnormalities of tears and blepharons, affecting the eye function of patients. Therefore, it is of important research value to analyze the correlation between T2DM-induced OCs and function of tears and blepharons.

Deep learning (DL) is widely used in the medical field and has unique application value. In recent years, DL is mainly used in clinical image analysis, clinical decision support, biomedical engineering, and health management and prevention. It has a very broad application prospect in the medical field, which can help doctors and researchers to diagnose and treat diseases more accurately, and improve the QOL and health status of patients [11,12]. Therefore, this work explored the research progress on diagnosing and treating diabetes and OCs based on DL, and analyzed the application value of DL in eye imaging image analysis. It aimed to give a guidance and reference for the prevention, control, and treatment of patients with T2DM and OCs.

2 Research progress of T2DM and OCs

2.1 Diabetic retinopathy (DR)

2.1.1 Pathogenesis

There are two types of DR: non-proliferative DR (NPDR) and proliferative DR. NPDR mainly includes microangiopathy and sclerotic lesions, while hyperplastic DR occurs on the basis of NPDR, including neovascularization and vitreous hemorrhage. The pathogenesis of DR is complex, which is related to hyperglycemia, vascular hyperplasia factors, oxidative stress, hypertension, hyperlipidemia, and other factors [13]. The hyperglycemia state of diabetes patients will lead to the damage of endothelial cells in retinal micro-vessels, increase the permeability of capillaries, and then promote the seepage of retina, the formation of edema, vitreous hemorrhage, and other diseases. Hyperglycemia state can also stimulate retinal vascular endothelial cells and retinal pigment epithelial cells to release a variety of vascular proliferation factors, such as vascular endothelial growth factor (VEGF) and keratine epithelial growth factor. These factors can cause capillary neovascularization and the formation of new blood vessels, which can then lead to hemorrhage and retinal edema and other diseases [14]. Hyperglycemia state can also lead to increased oxidative stress in the retina, promote retinal cell apoptosis and inflammatory response, and then accelerate the process of retinopathy. Hypertension and hyperlipidemia are common in patients with diabetes, and hypertension may aggravate the severity and progression of retinopathy. Prieto Del Cura and Gonzalez-Guijarro [15] discussed the clinical predictors of DR progression and found that poor blood glucose control, systemic hypertension, diabetes duration, dyslipidemia, and microalbuminuria were the main risk factors for the development and progression of DR. Increased aortic sclerosis has also been identified as a prognostic marker for DR and peripheral neuropathy. Bu et al. [16] found that patients with DR may be related to hypertension, high body mass index, metabolic abnormalities, and duration of diabetes, and found that aging, other complications, and metabolic syndrome are also related to DR. The pathogenesis of DR is very complex and involves the interaction of many factors. Therefore, in the aspect of prevention and treatment of DR, a comprehensive consideration of many factors should be taken to take effective measures for treatment and management. Figure 1 shows the pathogenesis of DR.

Figure 1 
                     Schematic diagram of the pathogenesis of DR.
Figure 1

Schematic diagram of the pathogenesis of DR.

2.1.2 Treatment

Blood sugar control is the most basic method to treat DR. By controlling blood sugar level, the occurrence and progression of retinopathy can be reduced or delayed. Drug treatment mainly includes hormone drugs, photosensitizers, and anti-VEGF drugs, which can reduce retinal edema, control the generation of new blood vessels, and reduce vitreous hemorrhage. Laser therapy is an effective method for the treatment of retinopathy, mainly suitable for early mild DR, including laser photocoagulation and laser photochemistry two ways. Injection therapy is a new treatment method, which can inhibit the generation and growth of new blood vessels and reduce bleeding and edema through injection of anti-VEGF drugs [17]. For severe DR, such as vitreous hemorrhage and retinal detachment, surgical treatment, such as vitrectomy and retinal reduction, is required [18]. For different types and degrees of DR, a variety of treatment methods should be considered comprehensively and individualized treatment programs should be adopted. Meanwhile, attention should also be paid to the prevention and management of the occurrence and progression of diabetes, to fundamentally reduce or avoid the occurrence of retinopathy.

2.2 Keratopathy

2.2.1 Pathogenesis

Diabetes keratopathy is one of the most common OCs in patients with diabetes. The hyperglycemia state of diabetes patients will lead to metabolic disorders of corneal epithelium cells, increase water content of corneal matrix, relaxation of cornea, loss of transparency and elasticity, and occurrence of keratopathy [19]. The state of hyperglycemia promotes the combination of glucose and cystine and other substances to form AGEs, which can accumulate on the cornea, cause damage to the function of corneal epithelium and endothelial cells, and affect the transparency and metabolism of the cornea [20]. The state of hyperglycemia can also lead to hypoxia of retina and cornea, cause cell necrosis and apoptosis, and further aggravate the severity of keratopathy. The state of hyperglycemia can also stimulate corneal endothelial cells and corneal stromal cells to release various vascular hyperplasia factors, cause capillary neovascularity, and then lead to corneal edema, corneal ulcers, and other lesions [21]. The state of hyperglycemia can also lead to the increase of immune inflammatory response in the cornea and promote the process of keratopathy. Zagon et al. [22] found that KCNQ1OT1/miR-214/caspase-1 signaling pathway represents a new mechanism for the progression of endothelial keratopathy in diabetes, and KCNQ1OT1 may be a new therapeutic target. The pathogenesis of diabetes keratopathy is multifaceted, and it is necessary to consider the characteristics of the systemic conditions and eye lesions of diabetes patients and take effective treatment measures. Patients with diabetes should prevent and treat the occurrence of diabetes keratopathy by checking their eye health status regularly, controlling blood sugar and blood pressure. Figure 2 shows the pathogenesis of keratopathy.

Figure 2 
                     Schematic diagram of pathogenesis of keratopathy.
Figure 2

Schematic diagram of pathogenesis of keratopathy.

2.2.2 Treatment

The main treatment of diabetes keratopathy is to control blood sugar level, which can slow down the process of keratopathy and reduce the risk of developing diabetes keratopathy [23]. Common methods to control blood sugar include diet, exercise, oral medication, and insulin injections. If diabetes patients develop ocular surface xerosis, artificial tear eye drops can be used to lubricate the cornea and relieve symptoms [24]. Some repairing additives can help corneal epithelial cells repair damaged tissue and promote the repair and regeneration of the corneal surface. Anti-inflammatory drugs, such as corneal lubricants or topical corticosteroids, can be used for inflammatory reactions caused by diabetes keratopathy [25]. For vision problems caused by keratopathy, optical treatments such as orthokeratology lenses or corneal transplants can be applied to improve vision. Some implantable medical devices, such as corneal rings, can be used for the treatment of diabetes keratopathy [26]. According to different types and severity of diabetes keratopathy, doctors will choose different treatment methods or combination therapy. At the same time, patients with diabetes should also actively control blood sugar, blood pressure and blood lipid, and check eye conditions regularly to prevent the occurrence of diabetes keratopathy.

2.3 Xerophthalmia

2.3.1 Pathogenesis

Xerophthalmia caused by diabetes is a metabolic disease, which is related to the abnormal stability of tear film, with high incidence and difficult treatment. The tear film is a three-part coating of tears, mucus, and lipids that lubricates and protects the surface of the eye. The amount and quality of tears in patients with xerophthalmia are reduced, and the stability of tear film is decreased, leading to symptoms such as dryness and pain on the ocular surface [27]. Tears are secreted by lacrimal glands, auxiliary lacrimal glands, and other parts. In xerophthalmia patients, tear secretion in these parts is reduced or abnormal, resulting in insufficient lubrication of tears on the ocular surface. Environmental factors, too much time on electronic devices, and reduced blinking can cause tear film to evaporate too quickly, exacerbating eye fatigue and dryness. In patients with xerophthalmia, ocular surface epithelial cells are damaged or destroyed, which can easily lead to apoptosis of corneal epithelial cells and inflammatory reactions, aggravating xerophthalmia symptoms [28]. Studies have found that the imbalance of nerve regulation in xerophthalmia patients may also be one of the pathogeneses. The sympathetic and parasympathetic nerves play an important role in tears secretion and tear film stability, and the imbalance of nerve regulation may lead to reduced tears secretion or instability of tear film [29]. In addition, the immune regulation of patients with xerophthalmia may be disturbed, leading to ocular surface inflammation and autoimmune diseases, which may aggravate xerophthalmia symptoms. The onset of xerophthalmia is also related to other factors, such as drugs, diseases, surgery, and keratopathy. The pathogenesis of xerophthalmia is multifaceted, which requires comprehensive consideration of the systemic conditions and the characteristics of ocular lesions in patients with xerophthalmia, and effective treatment measures should be taken. Figure 3 demonstrates the pathogenesis of xerophthalmia.

Figure 3 
                     Pathogenesis of xerophthalmia.
Figure 3

Pathogenesis of xerophthalmia.

2.3.2 Treatment

Patients with xerophthalmia can undergo artificial tear drops, which lubricate the eyes and relieve symptoms of xerophthalmia. Depending on the specific condition of patients, doctor will recommend different types of artificial tears, including eye drops, creams, and more. Patients with xerophthalmia need to avoid working and living in unhealthy environments such as air-conditioned rooms and prolonged use of computers. In dry environments, the use of humidifiers can increase air humidity and help relieve xerophthalmia symptoms [30]. Patients with xerophthalmia can use some medications to relieve symptoms, such as short-term use of antihistamines and non-steroidal anti-inflammatory drugs. In addition, some artificial tears also contain pharmaceutical ingredients that can be therapeutic. Patients with abnormal neuromodulation in xerophthalmia may be treated with neuromodulation drugs to regulate the nervous system and improve symptoms. Some surface repair agents can help corneal epithelial cells repair damaged tissues and promote the repair and regeneration of corneal surface [31]. For vision problems caused by xerophthalmia, optical treatments such as orthokeratology lenses or corneal transplants can be used to improve vision. For some patients with severe xerophthalmia, surgical treatment may be considered. Surgical treatment includes lacrimal gland ostomy and lacrimal gland transplantation. Prasad et al. [32] discussed the effect of integrated Chinese and western medicine in treating diabetes related xerophthalmia, and found that integrated Chinese and western medicine may be effective in treating diabetes xerophthalmia, and inflammatory factors are potential biomarkers to test the therapeutic effect. The treatment of xerophthalmia requires different treatment methods or combination therapy according to the different conditions. Patients with xerophthalmia should actively control environmental factors, maintain good living habits, and undergo regular eye examinations to prevent the deterioration of the condition.

2.4 Glaucoma

2.4.1 Pathogenesis

The main characteristic of glaucoma is increased intraocular pressure, which is an important factor in the onset of glaucoma. Increased intraocular pressure may be due to uneven production and discharge of aqueous humor, or may be due to obstruction of aqueous humor discharge channels. Increased pressure in the eye can lead to damage of the optic nerve, which can affect vision. Li et al. [33] found that diabetes may lead to glaucoma optic neuropathy through increasing intraocular pressure or vascular lesions and direct damage to the optic nerve. Long-term high intraocular pressure can lead to atrophy of the optic nerve head and damage to optic nerve fibers, eventually leading to visual field loss or blindness. Glaucoma patients suffered ischemia, hypoxia, and atrophy of optic nerve and retinal blood vessels, leading to optic nerve atrophy and vision loss. In addition, ocular tissues of patients with glaucoma may have inflammatory reactions, resulting in increased intraocular pressure and optic nerve damage [34]. Glaucoma may have a certain genetic predisposition, and some people are at higher risk for the disease. Some gene mutations may lead to glaucoma-related symptoms such as increased intraocular pressure and optic nerve damage [35]. The onset of glaucoma may also be related to a number of other factors, such as age, gender, race, medication, and disease. The pathogenesis of glaucoma is multifaceted. Early detection, early intervention, and effective treatment can reduce the occurrence and development of glaucoma and protect patients’ vision. Figure 4 shows the schematic diagram of the pathogenesis of glaucoma.

Figure 4 
                     Pathogenesis of glaucoma.
Figure 4

Pathogenesis of glaucoma.

2.4.2 Treatment

The main treatment for glaucoma is drug therapy, which is the most common and effective way to control intraocular pressure. Drugs can slow and prevent damage to the optic nerve by reducing pressure in the eye. Drugs commonly used include drugs to reduce intraocular pressure, drugs to promote aqueous humor discharge, drugs to inhibit aqueous humor production, etc. Laser therapy can reduce intraocular pressure by enhancing the channel at the angle of the chamber to promote the discharge of aqueous humor [36]. The commonly used laser treatment methods include three kinds of laser therapy and laser small incision surgery. For some patients with refractory glaucoma, surgical treatment is needed to reduce intraocular pressure. The commonly used surgical treatment methods include filtration surgery and implant surgery [37]. Conservative treatment involves paying attention to lifestyle and keeping your eyes healthy. For example, it should avoid strenuous exercise and lifting heavy objects, get enough sleep, stop smoking, and limit alcohol consumption, and protect your eye health through eye exercises, eye massages, and eye hygiene. Patients with glaucoma should have their eye pressure, vision, and visual field checked regularly and receive timely treatment to prevent the condition from worsening.

2.5 Cataract

2.5.1 Pathogenesis

Cataract is a common eye disease in the elderly. It is a cataract of vision disorders caused by opacity of the lens. Oxidative stress is an important factor in cataract occurrence. Oxidative stress in the body can cause oxidation and damage to proteins in the lens, which can lead to a cataract of decreased transparency. T2DM is a risk factor for cataract occurrence. As the prevalence of T2DM increases, so will the burden of cataract-related vision loss. Dash et al. [38] analyzed specific risk factors of diabetes cataract and found that age and blood sugar control were always correlated with the occurrence of T2DM-induced cataract, but blood pressure, diabetes duration, gender, and aspirin use were not. Lipids and smoking are still possible risk factors. In the state of hyperglycemia, glycation end products will accumulate in the lens, leading to the cross-linking and aggregation of proteins, which will damage the lens structure and function, forming a cataract. Apoptosis of lens cells is also one of the important mechanisms of cataract occurrence. Apoptosis of lens cells leads to a cataract of decreased transparency and aggregation of proteins. Long-term exposure to ultraviolet rays can also lead to oxidation and damage of proteins in the lens, resulting in a cataract of cataract transparency [39]. Long-term use of medications such as steroids also contributes to the cataract. Other factors such as poor nutrition, eye inflammation, and trauma can also cause cataract occurrences. Early detection of interventions and effective treatment can slow the development of cataract and protect patients’ vision. Figure 5 shows the pathogenesis of cataract.

Figure 5 
                     Pathogenesis of cataract.
Figure 5

Pathogenesis of cataract.

2.5.2 Treatment

Surgery is by far the most common way to treat the cataract, and the most effective. Surgery can be performed to restore the patient’s vision through the replacement of an artificial lens. Common surgical methods include phacoemulsification and grinding. After surgery, it is usually necessary to wear an eye mask and eye drops, pay attention to postoperative care and review. The drug treatments focus on complications such as cataract inflammation and infections before or after surgery. Commonly used drugs include antibiotic eye drops, anti-inflammatory eye drops, and infusion [40]. Conservative treatment includes lifestyle and eye health such as avoiding strenuous exercise and lifting heavy objects, getting enough sleep, stop smoking, and limiting alcohol consumption. In addition, it can prevent cataract by taking the right amount of antioxidants such as vitamins E and C. For some special types of cataracts, such as the cataract of glaucoma and cataract of fundus diseases, different treatment measures should be taken for different causes. Cataract treatments require choosing different treatments, or combinations, depending on the patients’ conditions and causes. Patients should have their eye health checked regularly and receive timely treatment to prevent their condition from worsening.

3 Research progress of OCs and function of tears and blepharons

3.1 OCs and functions of tears

OCs is closely linked to the tears function. Tear is a protective film on the surface of eyes with functions of lubrication, cleaning, nutrition, and defense, which is one of the important factors in maintaining eye health. It can also provide nutrients and oxygen to protect the surface of eyes from bacterial and viral infections [41]. Eye diseases will affect the secretion and quality of tears, resulting in abnormal tears function. When there are problems with the secretion or excretion of tears, the normal physiological function of the eyes will be affected, resulting in a variety of eye diseases. Xerophthalmia is a disorder caused by insufficient production of tears or rapid evaporation of tears. Lack of tears can cause discomfort such as dry, sore, and itchy eyes. Common features of dry eye syndrome (DES) are abnormal tear film, and abnormalities associated with DES are the absence of tears due to insufficient supply or excessive loss, and abnormal tears composition. DES can disrupt the homeostasis of tear film and its adjacent structures and adversely affect its basic functions (such as supporting ocular surface epithelium and preventing microbial invasion) [42]. Treatments for xerophthalmia include lubricant drops, hot compresses, and eye massages aimed at increasing tears secretion and improving their quality. Glaucoma is a disease of the eye that causes damage to the optic nerve, often accompanied by increased pressure inside the eye. High intraocular pressure can affect the secretion and excretion of tears, resulting in insufficient tears and reduced tear quality. Treatments for glaucoma include lowering the pressure in the eye and lubricant drops to improve the quality of the tears and relieve discomfort. Cataract is a common eye disease in the elderly, which causes opacity of the lens, which affects vision [43]. Cataract patients often have symptoms of insufficient secretion of tears and decreased quality of tears. Cataract treatments include surgery and lubricant drops to improve the quality of tears and protect the surface of the eye. Blepharitis are eye diseases caused by bacterial infections caused by impaired secretion of sebaceous glands at the edges of the eyelids. Blepharitis patients often suffer from decreased quality of tears, resulting in uncomfortable symptoms such as dry and stinging eyes. Treatment for blepharitis includes eye cleaning, antibiotic eye drops, and hot compresses to improve the quality of tears and reduce inflammation [44]. Conjunctivitis can also cause discomfort such as reduced tears, red eyes, itching, and foreign body sensation. Blepharons adenitis can lead to the deterioration of tears quality, thus causing eye discomfort, blurred vision, and other symptoms [45]. Function of tears is very important to the health of the eyes, and various eye diseases are closely related to tears function. Therefore, to maintain good living habits, pay attention to eye hygiene, reasonable use of eyes, etc., are conducive to the maintenance of tears function and eye health. Figure 6 shows the function of tears and the pathogenesis of eye diseases, and Figure 7 demonstrates the effect of OCs on the function of tears.

Figure 6 
                  Function of tears and mechanism of eye diseases.
Figure 6

Function of tears and mechanism of eye diseases.

Figure 7 
                  Effect of OCs on tears function.
Figure 7

Effect of OCs on tears function.

The change of tear secretion in diabetes patients is related to multiple peripheral neuropathies in diabetes patients [46,47], abnormal glucose metabolism [48], neurotransmitters [49,50], and extracellular matrix components [51]. In diabetes, the blood sugar increases, the content of inositol in nerve tissue decreases, the metabolism of phosphatidylinositol decreases, and the activity of protein kinase C decreases, which affects the phosphorylation of Na+–K+ ATPase, resulting in the decrease of activity, the increase of intracellular Na+, the decrease of transmembrane Na+ concentration gradient, the slowing of nerve conduction speed, the decline of corneal sensation, and the reduction of tear secretion. Herber et al. found that the tear protein composition of DM patients is different from that of normal individuals [52]. Kalló et al. showed that diabetes patients are different from normal people in terms of tear protein content and saturation, and also different from ordinary dry eye patients. The change of tear protein in diabetes patients is related to the course of diabetes, and the change is obvious in patients with long course of disease [53]. Nokhoijav et al. found that Apo (a-I) in tears of T2DM patients was significantly increased and closely related to the severity of DR, but no expression of Apo (a-I)-related genes was detected [54]. Kuo et al. found that the distribution of tear film lipid layer (TFLL) in DM patients was uneven, tear film rupture time and corneal sensation were decreased, suggesting that the function of tear lipid layer in diabetes patients was reduced and related to diabetes corneal epithelial lesions [55].

3.2 OCs and function of blepharons

Blepharons are secretory organs located on the inner side of the eyelid, which are part of the eyelid and consist of glands, glandular ducts, and glandular ducts that act as a protective barrier to the eye. Its main function is to secrete oil, water, protein, and other substances, maintain the lubrication and protection of the eye surface. Blepharons not only keep tears stable and clean, but also protect the ocular surface area from external irritation and infection. Studies have shown that the TFLL stabilizes the air/tears surface of the human eye. Blepharons glandular dysfunction (MGD) can lead to quantitative and qualitative changes in TFLL main components (>93%). The oily secretion of blepharons lipid is the main cause of DES, and up to 86% of DES patients will show signs of MGD [56]. OCs are closely related to the function of blepharons, and the malfunction of blepharons will lead to a series of eye diseases. Blepharons adenitis is one of the main causes of blepharons dysfunction, which can lead to a decrease in the quality and quantity of blepharons secretions, thus affecting eye lubrication and protection. Symptoms of blepharons adenitis include dry eyes, eye pain, foreign body sensation, blurred vision, and so on. The blepharons gland secretes blepharons, which produce the lipid layer of the tear film, thus preventing excessive evaporation of tears. MGD is the primary cause of evaporative xerophthalmia, which is more common than dehydrated xerophthalmia. Non-invasive blepharons photography relies on infrared light and infrared sensitive cameras to reveal the morphology of blepharon glands in the upper and lower eyelids, while tears interferometry can be used for qualitative and quantitative evaluation of the lipid layer of the tear film [57]. Xerophthalmia is an eye disease caused by insufficient eye lubrication, and blepharons dysfunction is one of the main causes of xerophthalmia. Blepharons secrete oils that lubricate the tears and form a protective film that reduces their evaporation. If the blepharons do not produce enough oil, they can cause tears to evaporate too quickly, which can cause symptoms such as dry eyes, discomfort, and blurred vision. Blepharons disorder refers to the disorder of secretion and excretion of blepharons secretions, resulting in insufficient oil secretion or oil quality decline. Blepharons disorder will make the eye surface not smooth, causing dry eyes, pain, blurred vision, and other symptoms [58]. Blepharons is very important for eye health. To protect blepharons function, it is necessary to pay attention to eye hygiene, avoid eye infection and irritation, have regular eye examinations, and timely detect and treat blepharons function abnormalities and other eye diseases. In addition, some eye care measures, such as eye massage, hot compress, nutritional supplement, can also be performed to help restore and maintain blepharons functional health. Figure 8 illustrates the functional of blepharons.

Figure 8 
                  Functional diagram of blepharons.
Figure 8

Functional diagram of blepharons.

At present, few studies have focused on the influence of diabetes on the morphology and function of meibomian gland [59]. A large-scale epidemiological study found that diabetes is a risk factor for asymptomatic meibomian gland dysfunction (MGD) [60]. MGD is the most common cause of evaporative dry eye, which can alter the quality and quantity of lipids in the secretion of the meibomian gland [61,62]. Previous studies have proved that T2DM patients have more severe MGD than non-diabetes patients [63]. Fan et al. reported that compared with the healthy control group in their study, diabetes patients showed significantly worse meibomian gland changes, including higher meibomian gland abscission rate, lower number of expressible glands, and higher meibomian margin abnormality score [64]. At the same time, studies have pointed out that the loss rate of upper and lower meibomian glands in T2DM patients is significantly higher than that in non-diabetes patients [65]. Figure 9 demonstrates the impact of eyelid function on OCs.

Figure 9 
                  Effect of eyelid function on OCs.
Figure 9

Effect of eyelid function on OCs.

4 Application of DL in T2DM and OCs

DL is an artificial intelligence (AI) technology that enables the diagnosis and treatment of eye diseases by automatically extracting features and building models by learning and analyzing large amounts of data. In recent years, DL has been widely used in the field of eye diseases. DL is a special type of machine learning that can achieve relatively more efficient learning outcomes. It is a method of classifying and regressing various types of data by training multi-layer artificial neural network structures. DL is a type of learning that uses deep neural networks to process feature representation. After data input, the input data is abstracted into features layer by layer through a multi-layer network, and finally the features are converted into task targets. The feature abstraction process is entirely completed by the system network itself, without adding any manual operations. DL is a kind of machine learning technology based on neural network, which can automatically extract, learn, and understand features in data, and carry out tasks such as classification and recognition. In the field of eye diseases, DL can realize automatic diagnosis and classification of eye diseases through the analysis and processing of eye images and data, improving the accuracy and efficiency of diagnosis. Through DL algorithm, fundus images can be automatically analyzed, which can realize the accurate diagnosis of DR, macular degeneration, and other diseases. The specific implementation of DL is to construct a neural network to automatically discover the inherent laws and potential representations in training data to serve the ultimate goal [66]. At present, multiple DL algorithms have been applied to T2DM and OCs. The classification advantage of DL is mainly that it can automatically adjust and update the network weight feature parameters after the image is input to the convolutional neural network, directly achieving an “end-to-end” classification mode, eliminating the need for manual feature extraction [67]. The U-Net network [68] performs image segmentation through data augmentation, preserving more detailed feature information through rich skip connections. The network fuses deep and shallow features of the same scale through skip connections to obtain more detailed multi-scale feature information. CE Net network [69] proposes a context feature extraction module based on the U-Net network framework, which has achieved good results in the segmentation of retinal blood vessels and optic discs in the fundus. At present, it has been used in the research related to the classification of diabetes retinopathy. Under the joint action of convolution, pooling, nonlinear activation, and other operations, the convolution neural network extracts the feature expression of the original data from the input layer, and then carries out layer by layer abstract operations [70]. The convolution neural network can identify low specificity features such as bleeding, microaneurysms, and so on. Based on this, it classifies the images of diabetes retinopathy at five levels [71].

Tan et al. [72] found that DL algorithm can be an effective tool for risk stratification and screening of myopic macular degeneration and high myopia in some myopic people around the world. DL can also be applied to the diagnosis and treatment of eye diseases such as keratopathy, glaucoma, and cataract. Li et al. [73] developed a clinically feasible DL system for prediction of onset and progression of glaucoma based on color fundus photographs and stratified risk prediction, as well as clinical validation of the performance of an external population cohort. They found that AI model has high sensitivity and specificity to predict the incidence and progression of glaucoma in the future, which proves the feasibility of DL algorithm in the early detection and prediction of glaucoma progression. DL technology can automatically extract lesion features through the study and analysis of many retinal images to realize automatic diagnosis of retinopathy, including DR and macular degeneration. Zekavat et al. [74] used CNN to segment retinal micro-vessels, and calculated blood vessel density and fractal dimension as a measure of the complexity of blood vessel branches. Low retinal vascular fractal dimensions and density were found to be significantly associated with higher risk of event mortality, hypertension, congestive heart failure, renal failure, T2DM, sleep apnea, anemia, and multiple ocular diseases, as well as corresponding quantitative characteristics. DL technology can also automatically extract ocular structures and surgical risk features by learning and analyzing eye images, and realize planning and evaluation of cataract operations, including preoperative ocular morphology analysis and surgical risk assessment. In addition, DL technology can automatically identify different types of visual impairments, including myopia, farsightedness, astigmatism, etc., through the learning and analysis of vision test data, and provide personalized treatment plans. DL technology can automatically identify disease risk factors and lesion characteristics through the study and analysis of a large number of ocular disease data, so as to realize the prediction and screening of ocular diseases, including glaucoma, corneal diseases, and fundus lesions. Tsiknakis et al. [75] analyzed various steps of DL method in the DR detection pipeline based on fundus images, and proposed an AI-driven method for detecting and classifying DR on fundus retinal images, thus improving the detection and diagnosis efficiency. DL technology has a wide application prospect in the field of ophthalmology and is expected to provide more accurate and efficient solutions for the diagnosis, treatment, and prevention of eye diseases [76]. At present, the research and application of DL in the field of eye diseases is still in its infancy and needs further research and exploration. The continuous development and application of DL technology will bring more possibilities for the early diagnosis and treatment of eye diseases. Figure 10 shows the application of DL in T2DM and OCs.

Figure 10 
               Application of DL in T2DM and OCs.
Figure 10

Application of DL in T2DM and OCs.

Although the DL algorithm has potential application prospects in the research of diabetes-related ophthalmopathy, the structural features of diabetes retinopathy images are not obvious, and the overall signal-to-noise ratio is not high, which leads to many network models being unable to effectively extract features during training. Hence, it needs further research. In addition, in the application of DL in diabetes-related eye diseases, challenges such as data demand, opacity, generalization ability, data deviation, privacy issues, and sample imbalance need to be overcome to ensure its effectiveness and reliability in clinical practice.

5 Conclusion

T2DM is difficult to treat, with many complications and complex clinical symptoms, which seriously threaten the normal life of patients. Patients with T2DM and OCs without timely treatment will worsen the disease and increase the rate of blindness in patients. Tears and blepharons, as two important secretions on the surface of eyes, have the function of protecting the health of the surface of eyes. The occurrence of OC may be affected by abnormal function of tears and blepharons. This work reviewed the main OCs of T2DM and its pathogenesis and treatment, analyzed the correlation between OCs and function of tears and blepharons, and explored the application of DL in T2DM and OCs. It aimed to give a theoretical basis for the prevention, control, and treatment of patients with T2DM and OCs.

  1. Funding information: Authors state no funding involved.

  2. Author contributions: Xiaohong Wang: Methodology, Jian Fang (Corresponding Author): Writing, Lina Yang: Visualization.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

References

[1] Romero AP. Ocular complications of diabetes and therapeutic approaches. J Clin Med. 2022;11(17):5170. 10.3390/jcm11175170.Search in Google Scholar PubMed PubMed Central

[2] Seewoodhary M. An overview of diabetic retinopathy and other ocular complications of diabetes mellitus. Nurs Stand (R Coll Nurs (Gt Br): 1987). 2021;36(7):71–6. 10.7748/ns.2021.e11696.Search in Google Scholar PubMed

[3] Dereci S, Hizli S, Bolu S, Asik A, Direkci I, Karadag AS. Evaluation of eye health in children with type 1 diabetes mellitus and celiac disease. Niger J Clin Pract. 2022;25(11):1785–91. 10.4103/njcp.njcp_1985_21.Search in Google Scholar PubMed

[4] Creuzot-Garcher C, Massin P, Srour M, Baudin F, Dot C, Nghiem-Buffet S, et al. Epidemiology of treated diabetes ocular complications in France 2008–2018 – the LANDSCAPE French Nationwide Study. Pharmaceutics. 2022;14(11):2330. 10.3390/pharmaceutics14112330.Search in Google Scholar PubMed PubMed Central

[5] Owolabi EO, Goon DT, Ajayi AI, Adeniyi OV, Chu KM. Coverage of diabetes complications screening in rural Eastern Cape, South Africa: a cross-sectional survey. S Afr Family Pract: Off J S Afr Acad Fam Pract/Prim Care. 2022;64(1):e1–6. 10.4102/safp.v64i1.5447.Search in Google Scholar PubMed PubMed Central

[6] Andersen J, Baun O, Aamand HE. Tear secretion in juvenile diabetics with and without autonomic neuropathy. Acta Ophthalmol. 1985;63(1):93–6. 10.1111/j.1755-3768.1985.tb05223.x.Search in Google Scholar PubMed

[7] Yeung A, Dwarakanathan S. Diabetic keratopathy. Dis-a-Mon: DM. 2021;67(5):101135. 10.1016/j.disamonth.2021.101135.Search in Google Scholar PubMed

[8] Patnaik K, Pradeep AR, Nagpal K, Karvekar S, Singh P, Raju A. Human chemerin correlation in gingival crevicular fluid and tear fluid as markers of inflammation in chronic periodontitis and type-2 diabetes mellitus. J Investig Clin Dent. 2017;8(1):12181. 10.1111/jicd.12181.Search in Google Scholar PubMed

[9] Rosenberg K. Frequent eye examinations urged for children with type 2 diabetes. Am J Nurs. 2022;122(4):57. 10.1097/01.NAJ.0000827352.29785.28.Search in Google Scholar PubMed

[10] Sahin GO, Dadaci Z, Ozer TT. Two cases of tinea ciliaris with blepharitis due to Microsporum audouinii and Trichophyton verrucosum and review of the literature. Mycoses. 2014;57(9):577–80. 10.1111/myc.12201.Search in Google Scholar PubMed

[11] Cheung CY, Ran AR, Wang S, Chan VTT, Sham K, Hilal S, et al. A deep learning model for detection of Alzheimer’s disease based on retinal photographs: a retrospective, multicentre case–control study. Lancet Digit Health. 2022;4(11):e806–15. 10.1016/S2589-7500(22)00169-8.Search in Google Scholar PubMed

[12] Ruamviboonsuk P, Tiwari R, Sayres R, Nganthavee V, Hemarat K, Kongprayoon A, et al. Real-time diabetic retinopathy screening by deep learning in a multisite national screening programme: a prospective interventional cohort study. Lancet Digit Health. 2022;4(4):e235–44. 10.1016/S2589-7500(22)00017-6.Search in Google Scholar PubMed

[13] Ciprés M, Satue M, Melchor I, Gil-Arribas L, Vilades E, Garcia-Martin E. Retinal neurodegeneration in patients with type 2 diabetes mellitus without diabetic retinopathy. Arch Soc Esp Oftalmol. 2022;97(4):205–18. 10.1016/j.oftale.2022.02.009.Search in Google Scholar PubMed

[14] Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Invest. 2021;12(8):1322–5. 10.1111/jdi.13480.Search in Google Scholar PubMed PubMed Central

[15] Prieto Del Cura MDM, Gonzalez-Guijarro JJ. Impact of ocular complications on visual outcomes in adult patients with uveitis. Cureus. 2022;14(1):e21370. 10.7759/cureus.21370.Search in Google Scholar PubMed PubMed Central

[16] Bu Y, Shih KC, Tong L. The ocular surface and diabetes, the other 21st century epidemic. Exp Eye Res. 2022;220:109099. 10.1016/j.exer.2022.109099.Search in Google Scholar PubMed

[17] Lin T, Gubitosi-Klug RA, Channa R, Wolf RM. Pediatric diabetic retinopathy: updates in prevalence, risk factors, screening, and management. Curr Diabetes Rep. 2021;21(12):56. 10.1007/s11892-021-01436-x.Search in Google Scholar PubMed

[18] Rabhi S, Blanchard F, Diallo AM, Zeghlache D, Lukas C, Berot A, et al. Temporal deep learning framework for retinopathy prediction in patients with type 1 diabetes. Artif Intell Med. 2022;133:102408. 10.1016/j.artmed.2022.102408.Search in Google Scholar PubMed

[19] Margolis TP. Neurotrophic keratopathy: ophthalmology’s diabetic foot problem. Eye Contact Lens. 2021;47(3):136–9. 10.1097/ICL.0000000000000774.Search in Google Scholar PubMed

[20] Bian Y, Ma KK, Hall NE, Elze T, Lorch A, Miller JW, et al. Neurotrophic keratopathy in the United States: an intelligent research in sight registry analysis. Ophthalmology. 2022;129(11):1255–62. 10.1016/j.ophtha.2022.06.019.Search in Google Scholar PubMed

[21] Bai P, Barkmeier AJ, Hodge DO, Mohney BG. Ocular sequelae in a population-based cohort of youth diagnosed with diabetes during a 50-year period. JAMA Ophthalmol. 2022;140(1):51–7. 10.1001/jamaophthalmol.2021.5052.Search in Google Scholar PubMed PubMed Central

[22] Zagon IS, Sassani JW, McLaughlin PJ. Sex differences in diabetic ocular surface complications and dysregulation of the OGF-OGFr pathway. J Diabetes Clin Res. 2022;4(1):20–4. 10.33696/diabetes.4.052.Search in Google Scholar PubMed PubMed Central

[23] Wei S, Fan J, Zhang X, Jiang Y, Zeng S, Pan X, et al. Sirt1 attenuates diabetic keratopathy by regulating the endoplasmic reticulum stress pathway. Life Sci. 2021;265:118789. 10.1016/j.lfs.2020.118789.Search in Google Scholar PubMed

[24] Guan H, Huang C, Lu D, Chen G, Lin J, Hu J, et al. Label-free Raman spectroscopy: a potential tool for early diagnosis of diabetic keratopathy. Spectrochim Acta Part A Mol Biomol Spectrosc. 2021;256:119731. 10.1016/j.saa.2021.119731.Search in Google Scholar PubMed

[25] Hamed MA, Farag A, Zahran IS, Hafez A, Rizk MA, Abass M. Pycnogenol a promising remedy for diabetic keratopathy in experimentally induced corneal alkali burns in diabetic rats. BMC Vet Res. 2022;18(1):209. 10.1186/s12917-022-03307-3.Search in Google Scholar PubMed PubMed Central

[26] Amador-Muñoz DP, Conforti V, Matheus LM, Molano-Gonzalez N, Payán-Gómez C. Diabetes mellitus type 1 has a higher impact on corneal endothelial cell density and pachymetry than diabetes mellitus type 2, independent of age: a meta-regression model. Cornea. 2022;41(8):965–73. 10.1097/ICO.0000000000002841.Search in Google Scholar PubMed PubMed Central

[27] Nyankerh CNA, Boateng AK, Appah M. Ocular complications after COVID-19 vaccination, vaccine adverse event reporting system. Vaccines. 2022;10(6):941. 10.3390/vaccines10060941.Search in Google Scholar PubMed PubMed Central

[28] Rosenberg CR, Abazari A, Chou TY, Weissbart SB. Comparison of comorbid associations and ocular complications in herpes simplex and zoster keratitis. Ocul Immunol Inflamm. 2022;30(1):57–61. 10.1080/09273948.2020.1797115.Search in Google Scholar PubMed

[29] Uludag G, Hassan M, Matsumiya W, Pham BH, Chea S, Trong Tuong Than N, et al. Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further? Expert Opin Biol Ther. 2022;22(10):1275–91. 10.1080/14712598.2022.2100694.Search in Google Scholar PubMed

[30] Essuman VA, Tagoe NN, Essuman A, Abaidoo B, Akpalu J, Sackey HA, et al. A cross-sectional study of ocular changes in children and adolescents with diabetes mellitus in selected health facilities in Ghana. Int J Environ Res Public Health. 2022;19(9):5295. 10.3390/ijerph19095295.Search in Google Scholar PubMed PubMed Central

[31] Li W, Gong X, Wang W, Xiong K, Meng J, Li Y, et al. Association of different kinds of obesity with diabetic retinopathy in patients with type 2 diabetes. BMJ Open. 2022;12(5):e056332. 10.1136/bmjopen-2021-056332.Search in Google Scholar PubMed PubMed Central

[32] Prasad R, Floyd JL, Dupont M, Harbour A, Adu-Agyeiwaah Y, Asare-Bediako B, et al. Maintenance of enteral ACE2 prevents diabetic retinopathy in type 1 diabetes. Circ Res. 2023;132(1):e1–21. 10.1161/CIRCRESAHA.122.322003.Search in Google Scholar PubMed PubMed Central

[33] Li Y, Mitchell W, Elze T, Zebardast N. Association between diabetes, diabetic retinopathy, and glaucoma. Curr Diabetes Rep. 2021;21(10):38. 10.1007/s11892-021-01404-5.Search in Google Scholar PubMed

[34] Cui QN, Stein LM, Fortin SM, Hayes MR. The role of glia in the physiology and pharmacology of glucagon-like peptide-1: implications for obesity, diabetes, neurodegeneration and glaucoma. Br J Pharmacol. 2022;179(4):715–26. 10.1111/bph.15683.Search in Google Scholar PubMed PubMed Central

[35] Jiang Y, Xiao G, Han X, Zhu Z, Shang X, Xiong R, et al. Diabetes mellitus and incident glaucoma in Australia: a 10-year cohort study from the 45 and up study. Ann Transl Med. 2022;10(16):856. 10.21037/atm-22-41.Search in Google Scholar PubMed PubMed Central

[36] Shah D, Dhamankar R, Shetty V, Haldipurkar SS, Chipade P, Tanwar S, et al. Individual and combined effects of diabetes and glaucoma on total macular thickness and ganglion cell complex thickness: a cross-sectional analysis. J Ophthalmic Vis Res. 2022;17(4):505–14. 10.18502/jovr.v17i4.12303.Search in Google Scholar PubMed PubMed Central

[37] Kesharwani P, Kumari K, Gururani R, Jain S, Sharma S. Approaches to address PK-PD challenges of conventional liposome formulation with special reference to cancer, Alzheimer’s, diabetes, and glaucoma: an update on modified liposomal drug delivery system. Curr Drug Metab. 2022;23(9):678–92. 10.2174/1389200223666220609141459.Search in Google Scholar PubMed

[38] Dash S, Chougule A, Mohanty S. Correlation of albuminuria and diabetic retinopathy in type-II diabetes mellitus patients. Cureus. 2022;14(2):e21927. 10.7759/cureus.21927.Search in Google Scholar PubMed PubMed Central

[39] Alabdulwahhab KM. Senile cataract in patients with diabetes with and without diabetic retinopathy: a community-based comparative study. J Epidemiol Glob Health. 2022;12(1):56–63. 10.1007/s44197-021-00020-6.Search in Google Scholar PubMed PubMed Central

[40] Feldman-Billard S, Dupas B. Eye disorders other than diabetic retinopathy in patients with diabetes. Diabetes Metab. 2021;47(6):101279. 10.1016/j.diabet.2021.101279.Search in Google Scholar PubMed

[41] Piona C, Costantini S, Zusi C, Cozzini T, Pedrotti E, Marigliano M, et al. Early marker of ocular neurodegeneration in children and adolescents with type 1 diabetes: the contributing role of polymorphisms in mir146a and mir128a genes. Acta Diabetol. 2022;59(12):1551–61. 10.1007/s00592-022-01919-7.Search in Google Scholar PubMed PubMed Central

[42] Cai C, Liu Y, Li Y, Shi Y, Zou H, Bao Y, et al. Effectiveness of quality of care for patients with type 2 diabetes in China: findings from the Shanghai Integration Model (SIM). Front Med. 2022;16(1):126–38. 10.1007/s11684-021-0897-7.Search in Google Scholar PubMed

[43] Dong J, Chen R, Zhao H, Zhu Y. COVID-19 and ocular complications: a review of ocular manifestations, diagnostic tools, and prevention strategies. Adv Ophthalmol Pract Res. 2023;3(1):33–8. 10.1016/j.aopr.2022.11.001.Search in Google Scholar PubMed PubMed Central

[44] Koca S, Koca SB, İnan S. Ocular surface alterations and changes of meibomian glands with meibography in type 1 diabetic children. Int Ophthalmol. 2022;42(5):1613–21. 10.1007/s10792-021-02155-8.Search in Google Scholar PubMed

[45] Asiedu K, Dhanapalaratnam R, Krishnan AV, Kwai N, Poynten A, Markoulli M. Impact of peripheral and corneal neuropathy on markers of ocular surface discomfort in diabetic chronic kidney disease. Optom Vis Sci: Off Publ Am Acad Optom. 2022;99(11):807–16. 10.1097/OPX.0000000000001955.Search in Google Scholar PubMed

[46] Kesarwani D, Rizvi SWA, Khan AA, Amitava AK, Vasenwala SM, Siddiqui Z. Tear film and ocular surface dysfunction in diabetes mellitus in an Indian population. Indian J Ophthalmol. 2017;65(4):301–4. 10.4103/ijo.IJO_939_15.Search in Google Scholar PubMed PubMed Central

[47] Baldo FD, Magna L, Dondi F, Maramieri P, Catrina OM, Corradini S, et al. Comparison of serum fructosamine and glycated hemoglobin values for assessment of glycemic control in dogs with diabetes mellitus. Am J Vet Res. 2020;81(3):233–42. 10.2460/ajvr.81.3.233.Search in Google Scholar PubMed

[48] Fujishima H, Tsubota K. Improvement of corneal fluorescein staining in post cataract surgery of diabetic patients by an oral aldose reductase inhibitor, ONO-2235. Br J Ophthalmol. 2002;86(8):860–3. 10.1136/bjo.86.8.860.Search in Google Scholar PubMed PubMed Central

[49] Han SB, Yang HK, Hyon JY. Influence of diabetes mellitus on anterior segment of the eye. Clin Interv Aging. 2018;14:53–63. 10.2147/CIA.S190713.Search in Google Scholar PubMed PubMed Central

[50] Jeziorny K, Niwald A, Moll A, Piasecka K, Pyziak-Skupien A, Waszczykowska A, et al. Measurement of corneal thickness, optic nerve sheath diameter and retinal nerve fiber layer as potential new non-invasive methods in assessing a risk of cerebral edema in type 1 diabetes in children. Acta Diabetol. 2018;55(12):1295–301. 10.1007/s00592-018-1242-8.Search in Google Scholar PubMed PubMed Central

[51] Jeziorny K, Waszczykowska A, Barańska D, Szadkowska A, Młynarski W, Zmysłowska A. Can we effectively predict the occurrence of cerebral edema in children with ketoacidosis in the course of type 1 diabetes? Case report and literature review. J Pediatr Endocrinol Metab. 2020;33(2):319–22. 10.1515/jpem-2019-0440.Search in Google Scholar PubMed

[52] Herber S, Grus FH, Sabuncuo P, Augustin AJ. Two-dimensional analysis of tear protein patterns of diabetic patients. Electrophoresis. 2001;22(9):1838–44. 10.1002/1522-2683(200105)22:9<1838::AID-ELPS1838>3.0.CO;2-7.Search in Google Scholar

[53] Kalló G, Varga AK, Szabó J, Emri M, Tőzsér J, Csutak A, et al. Reduced level of tear antimicrobial and immunomodulatory proteins as a possible reason for higher ocular infections in diabetic patients. Pathogens (Basel, Switz). 2021;10(7):883. 10.3390/pathogens10070883.Search in Google Scholar

[54] Nokhoijav E, Guba A, Kumar A, Kunkli B, Kalló G, Káplár M, et al. Metabolomic analysis of serum and tear samples from patients with obesity and type 2 diabetes mellitus. Int J Mol Sci. 2022;23(9):4534. 10.3390/ijms23094534.Search in Google Scholar

[55] Kuo YK, Shao SC, Lin ET, Pan LY, Yeung L, Sun CC. Tear function in patients with diabetes mellitus: a systematic review and meta-analysis. Front Endocrinol. 2022;13:1036002. 10.3389/fendo.2022.1036002.Search in Google Scholar

[56] Zhou B, Shi Y, Fu R, Ni H, Gu L, Si Y, et al. Relationship between SGLT-2i and ocular diseases in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Front Endocrinol. 2022;13:907340. 10.3389/fendo.2022.907340.Search in Google Scholar

[57] Bayked EM, Workneh BD, Kahissay MH. Sufferings of its consequences; patients with type 2 diabetes mellitus in North-East Ethiopia, a qualitative investigation. Heliyon. 2022;8(2):e08871. 10.1016/j.heliyon.2022.e08871.Search in Google Scholar

[58] Dhillon N, Santiago C. Management of acute proliferative diabetic retinopathy related complications during the first COVID-19 wave. BMC Ophthalmol. 2022;22(1):119. 10.1186/s12886-022-02349-3.Search in Google Scholar

[59] Lin X, Xu B, Zheng Y, Coursey TG, Zhao Y, Li J, et al. Meibomian gland dysfunction in type 2 diabetic patients. J Ophthalmol. 2017;2017:3047867. 10.1155/2017/3047867.Search in Google Scholar

[60] Viso E, Rodríguez-Ares MT, Abelenda D, Oubiña B, Gude F. Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. Investig Ophthalmol Vis Sci. 2012;53(6):2601–6. 10.1167/iovs.11-9228.Search in Google Scholar

[61] Chao C, Tong L. Tear lactoferrin and features of ocular allergy in different severities of meibomian gland dysfunction. Optom Vis Sci: Off Publ Am Acad Optom. 2018;95(10):930–6. 10.1097/OPX.0000000000001285.Search in Google Scholar PubMed

[62] Sandra Johanna GP, Antonio LA, Andrés GS. Correlation between type 2 diabetes, dry eye and meibomian glands dysfunction. J Optom. 2019;12(4):256–62. 10.1016/j.optom.2019.02.003.Search in Google Scholar PubMed PubMed Central

[63] Wu H, Fang X, Luo S, Shang X, Xie Z, Dong N, et al. Meibomian glands and tear film findings in type 2 diabetic patients: a cross-sectional study. Front Med. 2022;9:762493. 10.3389/fmed.2022.762493.Search in Google Scholar PubMed PubMed Central

[64] Fan F, Li X, Li K, Jia Z. To find out the relationship between levels of glycosylated hemoglobin with meibomian gland dysfunction in patients with type 2 diabetes. Ther Clin Risk Manag. 2021;17:797–807. 10.2147/TCRM.S324423.Search in Google Scholar PubMed PubMed Central

[65] Yang Q, Liu L, Li J, Yan H, Cai H, Sheng M, et al. Evaluation of meibomian gland dysfunction in type 2 diabetes with dry eye disease: a non-randomized controlled trial. BMC Ophthalmol. 2023;23(1):44. 10.1186/s12886-023-02795-7.Search in Google Scholar PubMed PubMed Central

[66] Joshi S, Karule PT. A review on exudates detection methods for diabetic retinopathy. Biomed Pharmacother. 2018;97:1454–60. 10.1016/j.biopha.2017.11.009.Search in Google Scholar PubMed

[67] Yu S, Xiao D, Kanagasingam Y. Exudate detection for diabetic retinopathy with convolutional neural networks. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2017; 2017. p. 1744–7. 10.1109/EMBC.2017.8037180.Search in Google Scholar PubMed

[68] Zunair H, Ben Hamza A. Sharp U-Net: depthwise convolutional network for biomedical image segmentation. Comput Biol Med. 2021;136:104699. 10.1016/j.compbiomed.2021.104699.Search in Google Scholar PubMed

[69] Yang Z, Yu H, He Y, Sun W, Mao ZH, Mian A. Fully convolutional network-based self-supervised learning for semantic segmentation. IEEE Trans Neural Netw Learn Syst. 2022;35(1):132–42. 10.1109/TNNLS.2022.3172423.Search in Google Scholar PubMed

[70] Sklan JE, Plassard AJ, Fabbri D, Landman BA. Toward content based image retrieval with deep convolutional neural networks. Proc SPIE–Int Soc Opt Eng. 2015;9417:94172C. 10.1117/12.2081551.Search in Google Scholar PubMed PubMed Central

[71] Zhao Y, Rada L, Chen K, Harding SP, Zheng Y. Automated vessel segmentation using infinite perimeter active contour model with hybrid region information with application to retinal images. IEEE Trans Med Imaging. 2015;34(9):1797–807. 10.1109/TMI.2015.2409024.Search in Google Scholar PubMed

[72] Tan TE, Anees A, Chen C, Li S, Xu X, Li Z, et al. Retinal photograph-based deep learning algorithms for myopia and a blockchain platform to facilitate artificial intelligence medical research: a retrospective multicohort study. Lancet Digit Health. 2021;3(5):e317–29. 10.1016/S2589-7500(21)00055-8.Search in Google Scholar PubMed

[73] Li F, Su Y, Lin F, Li Z, Song Y, Nie S, et al. A deep-learning system predicts glaucoma incidence and progression using retinal photographs. J Clin Invest. 2022;132(11):e157968. 10.1172/JCI157968.Search in Google Scholar PubMed PubMed Central

[74] Zekavat SM, Raghu VK, Trinder M, Ye Y, Koyama S, Honigberg MC, et al. Deep learning of the retina enables phenome- and genome-wide analyses of the microvasculature. Circulation. 2022;145(2):134–50. 10.1161/CIRCULATIONAHA.121.057709.Search in Google Scholar PubMed PubMed Central

[75] Tsiknakis N, Theodoropoulos D, Manikis G, Ktistakis E, Boutsora O, Berto A, et al. Deep learning for diabetic retinopathy detection and classification based on fundus images: a review. Comput Biol Med. 2021;135:104599. 10.1016/j.compbiomed.2021.104599.Search in Google Scholar PubMed

[76] Rim TH, Lee CJ, Tham YC, Cheung N, Yu M, Lee G, et al. Deep-learning-based cardiovascular risk stratification using coronary artery calcium scores predicted from retinal photographs. Lancet Digit Health. 2021;3(5):e306–16. 10.1016/S2589-7500(21)00043-1.Search in Google Scholar PubMed

Received: 2023-07-25
Revised: 2023-09-20
Accepted: 2023-10-19
Published Online: 2024-01-27

© 2024 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Constitutive and evoked release of ATP in adult mouse olfactory epithelium
  3. LARP1 knockdown inhibits cultured gastric carcinoma cell cycle progression and metastatic behavior
  4. PEGylated porcine–human recombinant uricase: A novel fusion protein with improved efficacy and safety for the treatment of hyperuricemia and renal complications
  5. Research progress on ocular complications caused by type 2 diabetes mellitus and the function of tears and blepharons
  6. The role and mechanism of esketamine in preventing and treating remifentanil-induced hyperalgesia based on the NMDA receptor–CaMKII pathway
  7. Brucella infection combined with Nocardia infection: A case report and literature review
  8. Detection of serum interleukin-18 level and neutrophil/lymphocyte ratio in patients with antineutrophil cytoplasmic antibody-associated vasculitis and its clinical significance
  9. Ang-1, Ang-2, and Tie2 are diagnostic biomarkers for Henoch-Schönlein purpura and pediatric-onset systemic lupus erythematous
  10. PTTG1 induces pancreatic cancer cell proliferation and promotes aerobic glycolysis by regulating c-myc
  11. Role of serum B-cell-activating factor and interleukin-17 as biomarkers in the classification of interstitial pneumonia with autoimmune features
  12. Effectiveness and safety of a mumps containing vaccine in preventing laboratory-confirmed mumps cases from 2002 to 2017: A meta-analysis
  13. Low levels of sex hormone-binding globulin predict an increased breast cancer risk and its underlying molecular mechanisms
  14. A case of Trousseau syndrome: Screening, detection and complication
  15. Application of the integrated airway humidification device enhances the humidification effect of the rabbit tracheotomy model
  16. Preparation of Cu2+/TA/HAP composite coating with anti-bacterial and osteogenic potential on 3D-printed porous Ti alloy scaffolds for orthopedic applications
  17. Aquaporin-8 promotes human dermal fibroblasts to counteract hydrogen peroxide-induced oxidative damage: A novel target for management of skin aging
  18. Current research and evidence gaps on placental development in iron deficiency anemia
  19. Single-nucleotide polymorphism rs2910829 in PDE4D is related to stroke susceptibility in Chinese populations: The results of a meta-analysis
  20. Pheochromocytoma-induced myocardial infarction: A case report
  21. Kaempferol regulates apoptosis and migration of neural stem cells to attenuate cerebral infarction by O‐GlcNAcylation of β-catenin
  22. Sirtuin 5 regulates acute myeloid leukemia cell viability and apoptosis by succinylation modification of glycine decarboxylase
  23. Apigenin 7-glucoside impedes hypoxia-induced malignant phenotypes of cervical cancer cells in a p16-dependent manner
  24. KAT2A changes the function of endometrial stromal cells via regulating the succinylation of ENO1
  25. Current state of research on copper complexes in the treatment of breast cancer
  26. Exploring antioxidant strategies in the pathogenesis of ALS
  27. Helicobacter pylori causes gastric dysbacteriosis in chronic gastritis patients
  28. IL-33/soluble ST2 axis is associated with radiation-induced cardiac injury
  29. The predictive value of serum NLR, SII, and OPNI for lymph node metastasis in breast cancer patients with internal mammary lymph nodes after thoracoscopic surgery
  30. Carrying SNP rs17506395 (T > G) in TP63 gene and CCR5Δ32 mutation associated with the occurrence of breast cancer in Burkina Faso
  31. P2X7 receptor: A receptor closely linked with sepsis-associated encephalopathy
  32. Probiotics for inflammatory bowel disease: Is there sufficient evidence?
  33. Identification of KDM4C as a gene conferring drug resistance in multiple myeloma
  34. Microbial perspective on the skin–gut axis and atopic dermatitis
  35. Thymosin α1 combined with XELOX improves immune function and reduces serum tumor markers in colorectal cancer patients after radical surgery
  36. Highly specific vaginal microbiome signature for gynecological cancers
  37. Sample size estimation for AQP4-IgG seropositive optic neuritis: Retinal damage detection by optical coherence tomography
  38. The effects of SDF-1 combined application with VEGF on femoral distraction osteogenesis in rats
  39. Fabrication and characterization of gold nanoparticles using alginate: In vitro and in vivo assessment of its administration effects with swimming exercise on diabetic rats
  40. Mitigating digestive disorders: Action mechanisms of Mediterranean herbal active compounds
  41. Distribution of CYP2D6 and CYP2C19 gene polymorphisms in Han and Uygur populations with breast cancer in Xinjiang, China
  42. VSP-2 attenuates secretion of inflammatory cytokines induced by LPS in BV2 cells by mediating the PPARγ/NF-κB signaling pathway
  43. Factors influencing spontaneous hypothermia after emergency trauma and the construction of a predictive model
  44. Long-term administration of morphine specifically alters the level of protein expression in different brain regions and affects the redox state
  45. Application of metagenomic next-generation sequencing technology in the etiological diagnosis of peritoneal dialysis-associated peritonitis
  46. Clinical diagnosis, prevention, and treatment of neurodyspepsia syndrome using intelligent medicine
  47. Case report: Successful bronchoscopic interventional treatment of endobronchial leiomyomas
  48. Preliminary investigation into the genetic etiology of short stature in children through whole exon sequencing of the core family
  49. Cystic adenomyoma of the uterus: Case report and literature review
  50. Mesoporous silica nanoparticles as a drug delivery mechanism
  51. Dynamic changes in autophagy activity in different degrees of pulmonary fibrosis in mice
  52. Vitamin D deficiency and inflammatory markers in type 2 diabetes: Big data insights
  53. Lactate-induced IGF1R protein lactylation promotes proliferation and metabolic reprogramming of lung cancer cells
  54. Meta-analysis on the efficacy of allogeneic hematopoietic stem cell transplantation to treat malignant lymphoma
  55. Mitochondrial DNA drives neuroinflammation through the cGAS-IFN signaling pathway in the spinal cord of neuropathic pain mice
  56. Application value of artificial intelligence algorithm-based magnetic resonance multi-sequence imaging in staging diagnosis of cervical cancer
  57. Embedded monitoring system and teaching of artificial intelligence online drug component recognition
  58. Investigation into the association of FNDC1 and ADAMTS12 gene expression with plumage coloration in Muscovy ducks
  59. Yak meat content in feed and its impact on the growth of rats
  60. A rare case of Richter transformation with breast involvement: A case report and literature review
  61. First report of Nocardia wallacei infection in an immunocompetent patient in Zhejiang province
  62. Rhodococcus equi and Brucella pulmonary mass in immunocompetent: A case report and literature review
  63. Downregulation of RIP3 ameliorates the left ventricular mechanics and function after myocardial infarction via modulating NF-κB/NLRP3 pathway
  64. Evaluation of the role of some non-enzymatic antioxidants among Iraqi patients with non-alcoholic fatty liver disease
  65. The role of Phafin proteins in cell signaling pathways and diseases
  66. Ten-year anemia as initial manifestation of Castleman disease in the abdominal cavity: A case report
  67. Coexistence of hereditary spherocytosis with SPTB P.Trp1150 gene variant and Gilbert syndrome: A case report and literature review
  68. Utilization of convolutional neural networks to analyze microscopic images for high-throughput screening of mesenchymal stem cells
  69. Exploratory evaluation supported by experimental and modeling approaches of Inula viscosa root extract as a potent corrosion inhibitor for mild steel in a 1 M HCl solution
  70. Imaging manifestations of ductal adenoma of the breast: A case report
  71. Gut microbiota and sleep: Interaction mechanisms and therapeutic prospects
  72. Isomangiferin promotes the migration and osteogenic differentiation of rat bone marrow mesenchymal stem cells
  73. Prognostic value and microenvironmental crosstalk of exosome-related signatures in human epidermal growth factor receptor 2 positive breast cancer
  74. Circular RNAs as potential biomarkers for male severe sepsis
  75. Knockdown of Stanniocalcin-1 inhibits growth and glycolysis in oral squamous cell carcinoma cells
  76. The expression and biological role of complement C1s in esophageal squamous cell carcinoma
  77. A novel GNAS mutation in pseudohypoparathyroidism type 1a with articular flexion deformity: A case report
  78. Predictive value of serum magnesium levels for prognosis in patients with non-small cell lung cancer undergoing EGFR-TKI therapy
  79. HSPB1 alleviates acute-on-chronic liver failure via the P53/Bax pathway
  80. IgG4-related disease complicated by PLA2R-associated membranous nephropathy: A case report
  81. Baculovirus-mediated endostatin and angiostatin activation of autophagy through the AMPK/AKT/mTOR pathway inhibits angiogenesis in hepatocellular carcinoma
  82. Metformin mitigates osteoarthritis progression by modulating the PI3K/AKT/mTOR signaling pathway and enhancing chondrocyte autophagy
  83. Evaluation of the activity of antimicrobial peptides against bacterial vaginosis
  84. Atypical presentation of γ/δ mycosis fungoides with an unusual phenotype and SOCS1 mutation
  85. Analysis of the microecological mechanism of diabetic kidney disease based on the theory of “gut–kidney axis”: A systematic review
  86. Omega-3 fatty acids prevent gestational diabetes mellitus via modulation of lipid metabolism
  87. Refractory hypertension complicated with Turner syndrome: A case report
  88. Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
  89. Association of low attenuation area scores with pulmonary function and clinical prognosis in patients with chronic obstructive pulmonary disease
  90. Long non-coding RNAs in bone formation: Key regulators and therapeutic prospects
  91. The deubiquitinating enzyme USP35 regulates the stability of NRF2 protein
  92. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential diagnostic markers for rebleeding in patients with esophagogastric variceal bleeding
  93. G protein-coupled receptor 1 participating in the mechanism of mediating gestational diabetes mellitus by phosphorylating the AKT pathway
  94. LL37-mtDNA regulates viability, apoptosis, inflammation, and autophagy in lipopolysaccharide-treated RLE-6TN cells by targeting Hsp90aa1
  95. The analgesic effect of paeoniflorin: A focused review
  96. Chemical composition’s effect on Solanum nigrum Linn.’s antioxidant capacity and erythrocyte protection: Bioactive components and molecular docking analysis
  97. Knockdown of HCK promotes HREC cell viability and inner blood–retinal barrier integrity by regulating the AMPK signaling pathway
  98. The role of rapamycin in the PINK1/Parkin signaling pathway in mitophagy in podocytes
  99. Laryngeal non-Hodgkin lymphoma: Report of four cases and review of the literature
  100. Clinical value of macrogenome next-generation sequencing on infections
  101. Overview of dendritic cells and related pathways in autoimmune uveitis
  102. TAK-242 alleviates diabetic cardiomyopathy via inhibiting pyroptosis and TLR4/CaMKII/NLRP3 pathway
  103. Hypomethylation in promoters of PGC-1α involved in exercise-driven skeletal muscular alterations in old age
  104. Profile and antimicrobial susceptibility patterns of bacteria isolated from effluents of Kolladiba and Debark hospitals
  105. The expression and clinical significance of syncytin-1 in serum exosomes of hepatocellular carcinoma patients
  106. A histomorphometric study to evaluate the therapeutic effects of biosynthesized silver nanoparticles on the kidneys infected with Plasmodium chabaudi
  107. PGRMC1 and PAQR4 are promising molecular targets for a rare subtype of ovarian cancer
  108. Analysis of MDA, SOD, TAOC, MNCV, SNCV, and TSS scores in patients with diabetes peripheral neuropathy
  109. SLIT3 deficiency promotes non-small cell lung cancer progression by modulating UBE2C/WNT signaling
  110. The relationship between TMCO1 and CALR in the pathological characteristics of prostate cancer and its effect on the metastasis of prostate cancer cells
  111. Heterogeneous nuclear ribonucleoprotein K is a potential target for enhancing the chemosensitivity of nasopharyngeal carcinoma
  112. PHB2 alleviates retinal pigment epithelium cell fibrosis by suppressing the AGE–RAGE pathway
  113. Anti-γ-aminobutyric acid-B receptor autoimmune encephalitis with syncope as the initial symptom: Case report and literature review
  114. Comparative analysis of chloroplast genome of Lonicera japonica cv. Damaohua
  115. Human umbilical cord mesenchymal stem cells regulate glutathione metabolism depending on the ERK–Nrf2–HO-1 signal pathway to repair phosphoramide mustard-induced ovarian cancer cells
  116. Electroacupuncture on GB acupoints improves osteoporosis via the estradiol–PI3K–Akt signaling pathway
  117. Renalase protects against podocyte injury by inhibiting oxidative stress and apoptosis in diabetic nephropathy
  118. Review: Dicranostigma leptopodum: A peculiar plant of Papaveraceae
  119. Combination effect of flavonoids attenuates lung cancer cell proliferation by inhibiting the STAT3 and FAK signaling pathway
  120. Renal microangiopathy and immune complex glomerulonephritis induced by anti-tumour agents: A case report
  121. Correlation analysis of AVPR1a and AVPR2 with abnormal water and sodium and potassium metabolism in rats
  122. Gastrointestinal health anti-diarrheal mixture relieves spleen deficiency-induced diarrhea through regulating gut microbiota
  123. Myriad factors and pathways influencing tumor radiotherapy resistance
  124. Exploring the effects of culture conditions on Yapsin (YPS) gene expression in Nakaseomyces glabratus
  125. Screening of prognostic core genes based on cell–cell interaction in the peripheral blood of patients with sepsis
  126. Coagulation factor II thrombin receptor as a promising biomarker in breast cancer management
  127. Ileocecal mucinous carcinoma misdiagnosed as incarcerated hernia: A case report
  128. Methyltransferase like 13 promotes malignant behaviors of bladder cancer cells through targeting PI3K/ATK signaling pathway
  129. The debate between electricity and heat, efficacy and safety of irreversible electroporation and radiofrequency ablation in the treatment of liver cancer: A meta-analysis
  130. ZAG promotes colorectal cancer cell proliferation and epithelial–mesenchymal transition by promoting lipid synthesis
  131. Baicalein inhibits NLRP3 inflammasome activation and mitigates placental inflammation and oxidative stress in gestational diabetes mellitus
  132. Impact of SWCNT-conjugated senna leaf extract on breast cancer cells: A potential apoptotic therapeutic strategy
  133. MFAP5 inhibits the malignant progression of endometrial cancer cells in vitro
  134. Major ozonated autohemotherapy promoted functional recovery following spinal cord injury in adult rats via the inhibition of oxidative stress and inflammation
  135. Axodendritic targeting of TAU and MAP2 and microtubule polarization in iPSC-derived versus SH-SY5Y-derived human neurons
  136. Differential expression of phosphoinositide 3-kinase/protein kinase B and Toll-like receptor/nuclear factor kappa B signaling pathways in experimental obesity Wistar rat model
  137. The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review
  138. BA inhibits LPS-stimulated inflammatory response and apoptosis in human middle ear epithelial cells by regulating the Nf-Kb/Iκbα axis
  139. Role of circRMRP and circRPL27 in chronic obstructive pulmonary disease
  140. Investigating the role of hyperexpressed HCN1 in inducing myocardial infarction through activation of the NF-κB signaling pathway
  141. Characterization of phenolic compounds and evaluation of anti-diabetic potential in Cannabis sativa L. seeds: In vivo, in vitro, and in silico studies
  142. Quantitative immunohistochemistry analysis of breast Ki67 based on artificial intelligence
  143. Ecology and Environmental Science
  144. Screening of different growth conditions of Bacillus subtilis isolated from membrane-less microbial fuel cell toward antimicrobial activity profiling
  145. Degradation of a mixture of 13 polycyclic aromatic hydrocarbons by commercial effective microorganisms
  146. Evaluation of the impact of two citrus plants on the variation of Panonychus citri (Acari: Tetranychidae) and beneficial phytoseiid mites
  147. Prediction of present and future distribution areas of Juniperus drupacea Labill and determination of ethnobotany properties in Antalya Province, Türkiye
  148. Population genetics of Todarodes pacificus (Cephalopoda: Ommastrephidae) in the northwest Pacific Ocean via GBS sequencing
  149. A comparative analysis of dendrometric, macromorphological, and micromorphological characteristics of Pistacia atlantica subsp. atlantica and Pistacia terebinthus in the middle Atlas region of Morocco
  150. Macrofungal sporocarp community in the lichen Scots pine forests
  151. Assessing the proximate compositions of indigenous forage species in Yemen’s pastoral rangelands
  152. Food Science
  153. Gut microbiota changes associated with low-carbohydrate diet intervention for obesity
  154. Reexamination of Aspergillus cristatus phylogeny in dark tea: Characteristics of the mitochondrial genome
  155. Differences in the flavonoid composition of the leaves, fruits, and branches of mulberry are distinguished based on a plant metabolomics approach
  156. Investigating the impact of wet rendering (solventless method) on PUFA-rich oil from catfish (Clarias magur) viscera
  157. Non-linear associations between cardiovascular metabolic indices and metabolic-associated fatty liver disease: A cross-sectional study in the US population (2017–2020)
  158. Knockdown of USP7 alleviates atherosclerosis in ApoE-deficient mice by regulating EZH2 expression
  159. Utility of dairy microbiome as a tool for authentication and traceability
  160. Agriculture
  161. Enhancing faba bean (Vicia faba L.) productivity through establishing the area-specific fertilizer rate recommendation in southwest Ethiopia
  162. Impact of novel herbicide based on synthetic auxins and ALS inhibitor on weed control
  163. Perspectives of pteridophytes microbiome for bioremediation in agricultural applications
  164. Fertilizer application parameters for drip-irrigated peanut based on the fertilizer effect function established from a “3414” field trial
  165. Improving the productivity and profitability of maize (Zea mays L.) using optimum blended inorganic fertilization
  166. Application of leaf multispectral analyzer in comparison to hyperspectral device to assess the diversity of spectral reflectance indices in wheat genotypes
  167. Animal Sciences
  168. Knockdown of ANP32E inhibits colorectal cancer cell growth and glycolysis by regulating the AKT/mTOR pathway
  169. Development of a detection chip for major pathogenic drug-resistant genes and drug targets in bovine respiratory system diseases
  170. Exploration of the genetic influence of MYOT and MB genes on the plumage coloration of Muscovy ducks
  171. Transcriptome analysis of adipose tissue in grazing cattle: Identifying key regulators of fat metabolism
  172. Comparison of nutritional value of the wild and cultivated spiny loaches at three growth stages
  173. Transcriptomic analysis of liver immune response in Chinese spiny frog (Quasipaa spinosa) infected with Proteus mirabilis
  174. Disruption of BCAA degradation is a critical characteristic of diabetic cardiomyopathy revealed by integrated transcriptome and metabolome analysis
  175. Plant Sciences
  176. Effect of long-term in-row branch covering on soil microorganisms in pear orchards
  177. Photosynthetic physiological characteristics, growth performance, and element concentrations reveal the calcicole–calcifuge behaviors of three Camellia species
  178. Transcriptome analysis reveals the mechanism of NaHCO3 promoting tobacco leaf maturation
  179. Bioinformatics, expression analysis, and functional verification of allene oxide synthase gene HvnAOS1 and HvnAOS2 in qingke
  180. Water, nitrogen, and phosphorus coupling improves gray jujube fruit quality and yield
  181. Improving grape fruit quality through soil conditioner: Insights from RNA-seq analysis of Cabernet Sauvignon roots
  182. Role of Embinin in the reabsorption of nucleus pulposus in lumbar disc herniation: Promotion of nucleus pulposus neovascularization and apoptosis of nucleus pulposus cells
  183. Revealing the effects of amino acid, organic acid, and phytohormones on the germination of tomato seeds under salinity stress
  184. Combined effects of nitrogen fertilizer and biochar on the growth, yield, and quality of pepper
  185. Comprehensive phytochemical and toxicological analysis of Chenopodium ambrosioides (L.) fractions
  186. Impact of “3414” fertilization on the yield and quality of greenhouse tomatoes
  187. Exploring the coupling mode of water and fertilizer for improving growth, fruit quality, and yield of the pear in the arid region
  188. Metagenomic analysis of endophytic bacteria in seed potato (Solanum tuberosum)
  189. Antibacterial, antifungal, and phytochemical properties of Salsola kali ethanolic extract
  190. Exploring the hepatoprotective properties of citronellol: In vitro and in silico studies on ethanol-induced damage in HepG2 cells
  191. Enhanced osmotic dehydration of watermelon rind using honey–sucrose solutions: A study on pre-treatment efficacy and mass transfer kinetics
  192. Effects of exogenous 2,4-epibrassinolide on photosynthetic traits of 53 cowpea varieties under NaCl stress
  193. Comparative transcriptome analysis of maize (Zea mays L.) seedlings in response to copper stress
  194. An optimization method for measuring the stomata in cassava (Manihot esculenta Crantz) under multiple abiotic stresses
  195. Fosinopril inhibits Ang II-induced VSMC proliferation, phenotype transformation, migration, and oxidative stress through the TGF-β1/Smad signaling pathway
  196. Antioxidant and antimicrobial activities of Salsola imbricata methanolic extract and its phytochemical characterization
  197. Bioengineering and Biotechnology
  198. Absorbable calcium and phosphorus bioactive membranes promote bone marrow mesenchymal stem cells osteogenic differentiation for bone regeneration
  199. New advances in protein engineering for industrial applications: Key takeaways
  200. An overview of the production and use of Bacillus thuringiensis toxin
  201. Research progress of nanoparticles in diagnosis and treatment of hepatocellular carcinoma
  202. Bioelectrochemical biosensors for water quality assessment and wastewater monitoring
  203. PEI/MMNs@LNA-542 nanoparticles alleviate ICU-acquired weakness through targeted autophagy inhibition and mitochondrial protection
  204. Unleashing of cytotoxic effects of thymoquinone-bovine serum albumin nanoparticles on A549 lung cancer cells
  205. Erratum
  206. Erratum to “Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM”
  207. Erratum to “Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation”
  208. Retraction
  209. Retraction to “MiR-223-3p regulates cell viability, migration, invasion, and apoptosis of non-small cell lung cancer cells by targeting RHOB”
  210. Retraction to “A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis”
  211. Special Issue on Advances in Neurodegenerative Disease Research and Treatment
  212. Transplantation of human neural stem cell prevents symptomatic motor behavior disability in a rat model of Parkinson’s disease
  213. Special Issue on Multi-omics
  214. Inflammasome complex genes with clinical relevance suggest potential as therapeutic targets for anti-tumor drugs in clear cell renal cell carcinoma
  215. Gastroesophageal varices in primary biliary cholangitis with anti-centromere antibody positivity: Early onset?
Downloaded on 23.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0773/html
Scroll to top button